Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,236 public trials 880 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Recruiting

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

NCT06657144

Conditions
Adenocarcinoma Of Esophagus, Advanced Solid Tumor, Carcinoma, +26 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of Colorado - Aurora Cancer Center Aurora, Colorado, United States
  • Winship Cancer Center - Emory University Atlanta, Georgia, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed

NCT06885034

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • GSK Investigational Site Los Alamitos, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Santa Monica, California, United States
  • GSK Investigational Site Whittier, California, United States
View all 85 locations
View Trial Details
Recruiting

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

NCT05612347

Conditions
Colonic Diseases, Colorectal Adenoma, Colorectal Cancer, +12 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • Jennifer Moreno Department of Veterans Affairs Medical Cneter San Diego, California, United States
  • Kaiser Permanente Northern California Walnut Creek, California, United States
View all 22 locations
View Trial Details
Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

NCT07468071

Conditions
Advanced Solid Tumors Harboring the KRAS G12C Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations
  • Novartis Investigative Site Sint-Niklaas, Oost Vlaanderen, Belgium
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Kashiwa, Chiba, Japan
View Trial Details
Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

NCT05877599

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +47 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Newport Beach, California, United States
  • Research Site Santa Monica, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

NCT06820463

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • City of Hope National Medical Center /ID# 270255 Duarte, California, United States
  • UCLA - Santa Monica /ID# 270621 Santa Monica, California, United States
  • Yale New Haven Hospital /ID# 270565 New Haven, Connecticut, United States
  • University of Chicago Medical Center /ID# 271688 Chicago, Illinois, United States
View all 56 locations
View Trial Details

Related conditions